MCID: TRC062
MIFTS: 43

Tricuspid Atresia malady

Categories: Rare diseases, Cardiovascular diseases, Fetal diseases

Aliases & Classifications for Tricuspid Atresia

About this section
Sources:
11Disease Ontology, 13DISEASES, 31ICD10 via Orphanet, 40MESH via Orphanet, 48NIH Rare Diseases, 52OMIM, 54Orphanet, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Tricuspid Atresia:

Name: Tricuspid Atresia 52 11 48 54 13
 
Congenital Agenesis of the Tricuspid Valve 48

Characteristics:

Orphanet epidemiological data:

54
tricuspid atresia:
Inheritance: Not applicable; Prevalence: 1-9/100000 (Europe),1-9/100000 (Belgium),1-9/100000 (France),1-5/10000 (Germany),1-5/10000 (Ireland),1-9/100000 (Italy),1-9/100000 (Netherlands),1-9/100000 (Norway),1-9/100000 (Poland),1-9/100000 (Spain),1-5/10000 (Portugal),1-5/10000 (Switzerland),1-9/100000 (United Kingdom),1-9/100000 (Ukraine); Age of onset: Antenatal,Neonatal

Classifications:



External Ids:

OMIM52 605067
Disease Ontology11 DOID:0080169
Orphanet54 ORPHA1209
ICD10 via Orphanet31 Q22.4
MESH via Orphanet40 D018785
UMLS via Orphanet69 C0243002

Summaries for Tricuspid Atresia

About this section
Disease Ontology:11 A tricuspid valve disease characterized by a missing or abnormally developed tricuspid heart value at birth.

MalaCards based summary: Tricuspid Atresia, also known as congenital agenesis of the tricuspid valve, is related to ventricular septal defect and transposition of the great arteries. An important gene associated with Tricuspid Atresia is ZFPM2 (Zinc Finger Protein, FOG Family Member 2), and among its related pathways are Heart Development and Cardiac Progenitor Differentiation. Affiliated tissues include heart, lung and atrioventricular node, and related mouse phenotypes are craniofacial and embryo.

Wikipedia:71 Tricuspid atresia is a form of congenital heart disease whereby there is a complete absence of the... more...

Description from OMIM:52 605067

Related Diseases for Tricuspid Atresia

About this section

Diseases related to Tricuspid Atresia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 67)
idRelated DiseaseScoreTop Affiliating Genes
1ventricular septal defect10.3
2transposition of the great arteries10.2
3aortopulmonary window10.1
4congenital diarrhea 7 with exudative enteropathy10.0GDF1, NKX2-6
5ascending cholangitis10.0GDF1, NKX2-6
6aneurysm10.0
7dentine erosion10.0NKX2-5, NKX2-6
8dextrocardia10.0
9univentricular heart10.0
10vulvar apocrine adenocarcinoma10.0CRELD1, NKX2-6
11huriez syndrome9.9CRELD1, NKX2-6
12intestinal atresia9.9NKX2-6, ZFPM2
13vulvar sebaceous carcinoma9.9CRELD1, NKX2-6
14testicular germ cell tumor non-seminomatous9.9CRELD1, HEY2, NKX2-6
15myocardial infarction9.8
16wolff-parkinson-white syndrome9.8
17tetralogy of fallot9.8
18esophageal atresia9.8
19protein-losing enteropathy9.8
20esophagitis9.8
21double outlet left ventricle9.8
22tracheoesophageal fistula9.8
23malignant pineal area germ cell neoplasm9.7GDF1, NKX2-5, NKX2-6, ZFPM2
24rubinstein-taybi syndrome9.7
25hemophilia b9.7
26pulmonary atresia with intact ventricular septum9.7
27lung agenesis9.7
28coarctation of aorta9.7
29pulmonary arteriovenous fistulas9.7
30congenital methemoglobinemia9.7
31pulmonary hypertension9.7
32arteriovenous fistula9.7
33hypoplastic left heart syndrome9.7
34seckel syndrome9.7
35atrioventricular septal defect9.7
36phaeochromocytoma9.7
37atrioventricular block9.7
38left ventricular noncompaction9.7
39endocarditis9.7
40methemoglobinemia9.7
41heart disease9.7
42pulmonary valve stenosis9.7
43situs inversus9.7
44muscular dystrophy9.7
45hemophilia9.7
46complete atrioventricular canal9.7
47congenital mitral stenosis9.7
48cor triatriatum9.7
49heterotaxy9.7
50hypoplastic right heart syndrome9.7

Graphical network of the top 20 diseases related to Tricuspid Atresia:



Diseases related to tricuspid atresia

Symptoms & Phenotypes for Tricuspid Atresia

About this section


Clinical features from OMIM:

605067

MGI Mouse Phenotypes related to Tricuspid Atresia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053829.0GDF1, HEY2, MESP1, NKX2-5
2MP:00053808.5GDF1, HEY2, MESP1, NKX2-5, NKX2-6
3MP:00028738.5GDF1, MESP1, NKX2-5, NKX2-6, ZFPM2
4MP:00053858.2GDF1, HEY2, MESP1, NKX2-5, NKX2-6, ZFPM2
5MP:00053887.4GDF1, HEY2, MESP1, NKX2-5, NKX2-6, ZFPM2

Drugs & Therapeutics for Tricuspid Atresia

About this section

Drugs for Tricuspid Atresia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 29)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Bosentanapproved, investigationalPhase 2104147536-97-8104865
Synonyms:
-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
147536-97-8
174227-18-0
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide
4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide
4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
AC-148
AC1L2XN2
Actelion
Bosentan
Bosentan (INN)
Bosentan [USAN:INN:BAN]
Bosentan hydrate
C27H29N5O6S
CHEBI:51450
CHEMBL957
CID104865
D07538
DB00559
 
EN002863
HMS2090N14
I06-1873
KS-5062
L001086
LS-31532
MolPort-003-845-300
NCGC00167440-01
PDSP1_001731
PDSP2_001714
Ro 47-0203
Ro 47-0203/039
Ro-47-0203
Ro-47-0203/029
Ro-47-0203/039
TL8001039
Tracleer
UNII-XUL93R30K2
bosentan
bosentanum
bosentán
p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
p-tert-Butyl-N-[6-(2-hydroxyethoxy)
2Vasodilator AgentsPhase 23543
3Endothelin Receptor AntagonistsPhase 2218
4Sildenafil CitratePhase 2331171599-83-0
5Antihypertensive AgentsPhase 24207
6Phosphodiesterase InhibitorsPhase 21289
7Phosphodiesterase 5 InhibitorsPhase 2589
8CitrateNutraceuticalPhase 21160
9
Citric Acidnutraceutical, vet_approvedPhase 2116077-92-9311
Synonyms:
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Aciletten
Anhydrous citrate
Anhydrous citric acid
Chemfill
Citraclean
 
Citrate
Citretten
Citric acid
Citro
Citronensäure
E 330
Hydrocerol A
Kyselina citronova
Suby G
Uro-trainer
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
10
Dexmedetomidineapproved, vet_approvedPhase 159276631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
11Central Nervous System DepressantsPhase 113403
12Peripheral Nervous System AgentsPhase 123689
13Neurotransmitter AgentsPhase 118340
14Hypnotics and SedativesPhase 12616
15Analgesics, Non-NarcoticPhase 16501
16AnalgesicsPhase 111733
17Adrenergic AgentsPhase 15352
18Adrenergic AgonistsPhase 13027
19Adrenergic alpha-2 Receptor AgonistsPhase 1980
20Adrenergic alpha-AgonistsPhase 11734
21
Mechlorethamineapproved39751-75-24033
Synonyms:
.Beta.,.beta.'-Dichlorodiethyl-N-methylamine
1, 5-Dichloro-3-methyl-3-azapentane hydrochloride
126-85-2 (N-oxide)
2,2'-Dichloro-N-me
2,2'-Dichloro-N-methyldiethylamine
2,2'-Dichlorodiethyl-methylamine
2,2'-dichloro-N-methyldiethylamine
2-Chloro-N-(2-chloroethyl)-N-methylethanamine
302-70-5 (N-oxide, hydrochloride)
51-75-2
55-86-7 (HYDROCHLORIDE)
AC1L1H9H
Antimit
BRN 0605323
BSPBio_001947
Bis(2-chloroethyl)methylamine
Bis(beta-chloroethyl) methylamine
Bis(beta-chloroethyl)methylamine
C07115
C5H11Cl2N
CCRIS 447
CHEBI:28925
CHEMBL427
CID4033
Carolysine
Caryolysin
Caryolysine
Chloramine (the nitrogen mustard)
Chlorethazine
Chlormethine
Chlormethine (INN)
Chlormethine [INN:BAN]
Chlormethinum [INN-Latin]
Cloramin
Clormetina
Clormetina [INN-Spanish]
D07671
DB00888
Di(2-chloroethyl)methylamine
Dichlor amine
Dichloren
DivK1c_000759
EINECS 200-120-5
ENT-25294
Embechine
Embichin
HMS1920J15
HMS2091B04
HMS502F21
HN-2
HN2
HSDB 5083
I14-8708
IBS-L0033631
IDI1_000759
KBio1_000759
KBio2_001369
KBio2_003937
KBio2_006505
KBio3_001447
 
KBioGR_001448
KBioSS_001369
LS-7559
MBA
Me chloroethamine
Mebichloramine
Mechlorethamine
Mechlorethanamine
Mechloroethamine
Mecloretamina
Mecloretamina [Italian]
Methylbis(2-chloroethyl)amine
Methylbis(beta-chloroethyl)amine
Methyldi(2-chloroethyl)amine
Mitoxine (*Hydrochloride*)
MolPort-001-785-592
Mustargen
Mustine
Mustine note
Mutagen
N,N-Bis(2-chloroethyl)-N-methylamine
N,N-Bis(2-chloroethyl)methylamine
N,N-Di(chloroethyl)methylamine
N-Lost
N-Methyl lost
N-Methyl-2,2'-dichlorodiethylamine
N-Methyl-bis(2-chloroethyl)amine
N-Methyl-bis(beta-chloroethyl)amine
N-Methyl-bis-chloraethylamin
N-Methyl-bis-chloraethylamin [German]
N-Methyl-lost
N-Methyl-lost [German]
N-methyl-bis(2-chloroethyl)amine
NCGC00091835-02
NCGC00091835-03
NCGC00091835-04
NCGC00091835-05
NCI60_041682
NINDS_000759
NSC762
Nitol (*Hydrochloride*)
Nitrogen mustard
Nitrogen mustard (HN-2)
Nitrogranulogen
SPBio_000496
SPECTRUM1500375
Spectrum2_000448
Spectrum3_000484
Spectrum4_000924
Spectrum5_001702
Spectrum_000889
Stickstofflost (*Hydrochloride*)
Stickstofflost (ebewe)
T 1024
T-1024
TL 146
UNII-50D9XSG0VR
beta,Beta'-dichlorodiethyl-N-methylamine
beta,beta'-Dichlorodiethyl-N-methylamine
mechlorethamine
thyldiethylamine
β,β'-dichlorodiethyl-N-methylamine
22
Vitamin Capproved, nutraceutical53150-81-75785, 54670067
Synonyms:
(+)-Sodium L-ascorbate
(+)-ascorbate
(+)-ascorbic acid
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
3-Keto-L-gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
30208-61-8
33034_RIEDEL
33034_SIAL
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
AR-1J3435
Acid Ascorbic
Acide ascorbique
Acide ascorbique [INN-French]
Acido ascorbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
Antiscorbic vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Arco-cee
Ascoltin
Ascoltin (TN)
Ascor-B.I.D.
Ascorb
Ascorbajen
Ascorbate
Ascorbic Acid
Ascorbic Acid, Monosodium Salt
Ascorbic acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
BPBio1_000363
BSPBio_000329
C-Level
C-Long
C-Quin
C-Span
C-Vimin
C00072
C6H8O6
CCRIS 57
CE-VI-Sol
CHEBI:29073
CHEMBL196
CID5785
Cantan
Cantaxin
Caswell No. 061B
Catavin C
Ce lent
Ce-Mi-Lin
Ce-mi-lin
Ce-vi-sol
Cebicure
Cebid
Cebion
Cebione
Cecon
Cee-Caps TD
Cee-Vite
Cee-caps TD
Cee-vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-Caps TC
Cetane-Caps TD
Cetane-caps TC
Cetane-caps TD
Cetebe
Cetemican
Cevalin
 
Cevatine
Cevex
Cevi-Bid
Cevi-bid
Cevimin
Cevital
Cevitamate
Cevitamic acid
Cevitamin
Cevitan
Cevitex
Cewin
Chewcee
Ciamin
Cipca
Citriscorb
Citrovit
Colascor
Concemin
Cortalex
D00018
DB00126
Davitamon C
Dora-C-500
Duoscorb
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
HSDB 818
HiCee
Hicee
Hybrin
IDO-C
Ido-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina askorbova
Kyselina askorbova [Czech]
L(+)-Ascorbate
L(+)-Ascorbic acid
L-(+)-Ascorbate
L-(+)-Ascorbic Acid
L-(+)-Ascorbic acid
L-(+)-ascorbic acid
L-3-Ketothreohexuronic acid lactone
L-3-ketothreohexuronic acid
L-Ascorbate
L-Ascorbic Acid
L-Ascorbic acid
L-Ascorbic acid, free radical form
L-Lyxoascorbate
L-Lyxoascorbic acid
L-Threo-ascorbic acid
L-Threoascorbic acid
L-Xyloascorbate
L-Xyloascorbic acid
L-ascorbate
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-ascorbic acid
L-threo-hex-2-enono-1,4-lactone
LS-145
Laroscorbine
Lemascorb
Liqui-Cee
Liqui-cee
MLS002153776
Magnesium Ascorbicum
Magnorbin
Meri-C
Meri-c
MolPort-001-792-501
Monodehydroascorbic acid
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
NCI-C54808
NSC 33832
Natrascorb
Natrascorb injectable
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
Roscorbic
Rovimix C
SMR001233160
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
Sodascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100M
Vitace
Vitacee
Vitacimin
Vitacin
Vitamin C
Vitamin- C
Vitamin-?C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
acide ascorbique
acidum ascorbicum
acidum ascorbinicum
antiscorbic vita min
ascor-b.i.d
ascorbate
ascorbic acid
bmse000182
cee-caps td
cevibid
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
gamma-Lactone L-threo-Hex-2-enonate
gamma-Lactone L-threo-Hex-2-enonic acid
l-ascorbic acid
l-threo-hex-1-eofuranos-3-ulose
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
roscorbi c
vitamin C
ácido ascórbico
23Vitamins5282
24Micronutrients6001
25Trace Elements6001
26Antioxidants3050
27Protective Agents7443
28Tin Fluorides264
29diuretics1418

Interventional clinical trials:

(show all 11)
idNameStatusNCT IDPhase
1Sildenafil After the Fontan OperationCompletedNCT00507819Phase 2
2Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.CompletedNCT01292551Phase 2
3Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan ProcedureCompletedNCT00004828Phase 1
4Understanding Dexmedetomidine In Infants Post-Operative From Cardiac SurgeryCompletedNCT00573066Phase 1
5Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI TechniquesUnknown statusNCT01107990
6Biomarker Study for Heart Failure in Children With Single Ventricle PhysiologyCompletedNCT00571233
7Impact of Vitamin C on Endothelial Function and Exercise Capacity in Fontan-Palliated PatientsCompletedNCT00974025
8National Congenital Heart Disease AuditRecruitingNCT02303535
9Stress Echo 2020 - The International Stress Echo StudyRecruitingNCT03049995
10Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle AnatomyEnrolling by invitationNCT02614664
11Adult Pulmonary Valve Replacement: A Simple and Reproducible TechniqueTerminatedNCT00384163

Search NIH Clinical Center for Tricuspid Atresia

Genetic Tests for Tricuspid Atresia

About this section

Anatomical Context for Tricuspid Atresia

About this section

MalaCards organs/tissues related to Tricuspid Atresia:

36
Heart, Lung, Atrioventricular node, Liver

Publications for Tricuspid Atresia

About this section

Articles related to Tricuspid Atresia:

(show top 50)    (show all 443)
idTitleAuthorsYear
1
Tricuspid atresia associated with aortopulmonary window: diagnostic and therapeutic dilemmas. (27680574)
2016
2
Successful staged Fontan completion for a tricuspid atresia patient with left ventricular non-compaction. (26689445)
2016
3
Tricuspid Atresia with Non-compaction: An Early Experience with Implications for Surgical Palliation. (27942762)
2016
4
Modified Norwood Procedure for Tricuspid Atresia, Transposition of Great Arteries, and Hypoplastic Right Arch With Complete Vascular Ring. (27772616)
2016
5
Typical atrial flutter with muscular type tricuspid atresia. (27226496)
2016
6
Absent Pulmonary Valve Syndrome With Tricuspid Atresia, Ventricular Septal Defect, and Aneurysmal Dilated Pulmonary Artery: A Case Report of Successful Fontan Completion. (27549733)
2016
7
Giant left atrial appendage aneurysm in association with tricuspid atresia. (26758408)
2016
8
Improved Exercise Performance in Patients With Tricuspid Atresia After the Fontan-BjAPrk Modification With Pulsatile Systolic PulmonaryA Flow. (26680312)
2016
9
Parental Refusal of Surgery in an Infant With Tricuspid Atresia. (27940784)
2016
10
AV nodal ablation in tricuspid atresia; anatomical challenges. (27788993)
2016
11
Tricuspid Atresia IIc With a Vascular Ring: Novel Approach forA Fontan Completion. (26897207)
2016
12
Thrombolytics for late superior caval vein thrombus in a patient with tricuspid atresia and single-lung Glenn anastomosis. (26194906)
2016
13
Tricuspid Atresia 18 Years Post Glenn: Is Fontan Necessary in All Cases? (26426189)
2015
14
Influence of Morphology and Initial Surgical Strategy on Survival of Infants With Tricuspid Atresia. (26233275)
2015
15
Tricuspid atresia and pulmonary atresia in a child with Rubinstein-Taybi syndrome. (26085772)
2015
16
Surgical management of competing pulmonary blood flow affects survival before Fontan/Kreutzer completion in patients with tricuspid atresia type I. (26145767)
2015
17
Determination of a new mutation in MT-ND1 gene of a patient with dextrocardia, ventriculoarterial discordance, and tricuspid atresia. (25626582)
2015
18
Absent pulmonary valve, tricuspid atresia, and congenital heart block. (25548352)
2015
19
Truncus arteriosus, tricuspid atresia and partial anomalous pulmonary venous drainage: a unique form of univentricular heart. (25972595)
2015
20
Tricuspid atresia with truncus arteriosus: successful surgical treatment. (25087803)
2014
21
Successful hybrid management for a patient with tricuspid atresia and innominate vein obstruction. (25231417)
2014
22
A case of Seckel syndrome with tricuspid atresia. (25059015)
2014
23
Successful palliation of a child with left ventricular noncompaction cardiomyopathy and tricuspid atresia to Fontan procedure. (25087802)
2014
24
Integration of cardiac magnetic resonance imaging in pre-procedural planning and electroanatomical mapping for catheter ablation after a Fontan-Bjork correction of tricuspid atresia. (24970724)
2014
25
Tricuspid atresia with progressive ductal restriction in a fetus. (22729970)
2013
26
Fetal heterotaxy with tricuspid atresia, pulmonary atresia, and isomerism of the right atrial appendages at 22 weeks. (24147244)
2013
27
Congenital coronary arteriopathy and myocardial infarctions occur with tricuspid atresia. (22622686)
2013
28
Combined heart transplantation and thoracic endovascular aortic repair for heart failure secondary to tricuspid atresia palliated with Potts shunt. (23989821)
2013
29
Simplified approach for ablation of nodal reentrant tachycardia in a patient with tricuspid atresia and extracardiac Fontan palliation. (24775626)
2013
30
Crisscross heart with tricuspid atresia diagnosed in utero. (22958430)
2013
31
Tricuspid Atresia Associated with Truncus Arteriosus versus Aortopulmonary Window: Combining Fetal and Postnatal Echocardiography to Make the Diagnosis. (24033694)
2013
32
eComment. Balancing the pulmonary circulation in tricuspid atresia with an aortopulmonary window. (23868968)
2013
33
eReply. Re: Balancing the pulmonary circulation in tricuspid atresia with an aortopulmonary window. (23868969)
2013
34
Tricuspid atresia with aortopulmonary window: challenges in achieving a balanced circulation. (23628655)
2013
35
Simplified approach for ablation of nodal reentrant tachycardia in a patient with tricuspid atresia and extracardiac fontan palliation. (23153687)
2013
36
Percutaneous transluminal pulmonary valvuloplasty in a child with tricuspid atresia, ventricular septal defect, and severe pulmonary valve stenosis: Usefulness of the Femoral Artery Approach. (24030841)
2013
37
Ablation of atrioventricular nodal reentrant tachycardia in a patient with tricuspid atresia guided by electroanatomic mapping. (21091748)
2012
38
Three-dimensional mechanical dyssynchrony and myocardial deformation of the left ventricle in patients with tricuspid atresia after Fontan procedure. (22297084)
2012
39
Successful reoperation of the valveless calcified right atrium to right ventricle conduit in an adult patient with tricuspid atresia after Fontan procedure. (22223698)
2012
40
Two heterozygous mutations in NFATC1 in a patient with Tricuspid Atresia. (23226213)
2012
41
Aorto-right ventricular tunnel causing functional tricuspid atresia. (22529068)
2012
42
Modified bjork procedure for tricuspid atresia with pulmonary hypertension. (21973011)
2011
43
Tricuspid atresia with absent pulmonary valve and intact ventricular septum: a rare association. (21392265)
2011
44
Persistent left superior vena cava draining into an unroofed coronary sinus in tricuspid atresia: an uncommon anomaly. (21360004)
2011
45
Misleading unilateral V/Q and CTPA abnormality following previous cardiac surgery for tricuspid atresia. (21295210)
2011
46
63-year survival after Blalock-Taussig shunt operation in a patient with single ventricle, tricuspid atresia, and pulmonary stenosis. (21426531)
2011
47
Left juxtaposed atrial appendages in a patient with dextrocardia and tricuspid atresia: TEE images. (21636938)
2011
48
A case of tricuspid atresia with normally related great vessels and coarctation of the aorta. (21702887)
2011
49
Atrioventricular septal defect with coexisting tricuspid atresia. (21262068)
2011
50
Prenatal diagnosis of tricuspid atresia with hypoplastic right ventricle associated with truncus arteriosus communis type II. (19533158)
2010

Variations for Tricuspid Atresia

About this section

Expression for genes affiliated with Tricuspid Atresia

About this section
Search GEO for disease gene expression data for Tricuspid Atresia.

Pathways for genes affiliated with Tricuspid Atresia

About this section

Pathways related to Tricuspid Atresia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6HEY2, NKX2-5
29.1MESP1, NKX2-5

GO Terms for genes affiliated with Tricuspid Atresia

About this section

Biological processes related to Tricuspid Atresia according to GeneCards Suite gene sharing:

(show all 25)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of cardiac muscle cell proliferationGO:006004510.5HEY2, ZFPM2
2cardiac muscle tissue developmentGO:004873810.4NKX2-5, ZFPM2
3atrial septum morphogenesisGO:006041310.4HEY2, NKX2-5
4cardiac ventricle morphogenesisGO:000320810.3HEY2, NKX2-5
5heart trabecula formationGO:006034710.3HEY2, NKX2-5
6outflow tract septum morphogenesisGO:000314810.3NKX2-5, ZFPM2
7negative regulation of cardiac muscle cell apoptotic processGO:001066710.3HEY2, NKX2-5
8outflow tract morphogenesisGO:000315110.3HEY2, NKX2-5
9atrial cardiac muscle cell developmentGO:005501410.3NKX2-5, NKX2-6
10embryonic heart tube developmentGO:003505010.3NKX2-5, NKX2-6
11pharyngeal system developmentGO:006003710.2NKX2-5, NKX2-6
12BMP signaling pathwayGO:003050910.2GDF1, NKX2-5
13right ventricular cardiac muscle tissue morphogenesisGO:000322110.1NKX2-5, ZFPM2
14cardiac muscle cell differentiationGO:00550079.9MESP1, NKX2-5
15cardiac ventricle formationGO:00032119.9MESP1, NKX2-5
16heart loopingGO:00019479.9MESP1, NKX2-5
17heart morphogenesisGO:00030079.9MESP1, NKX2-5
18vasculogenesisGO:00015709.7HEY2, NKX2-5, ZFPM2
19ventricular trabecula myocardium morphogenesisGO:00032229.6HEY2, NKX2-5
20ventricular cardiac muscle cell developmentGO:00550159.6HEY2, NKX2-5, NKX2-6
21ventricular septum morphogenesisGO:00604129.5HEY2, NKX2-5, ZFPM2
22heart developmentGO:00075079.5HEY2, NKX2-5, NKX2-6, ZFPM2
23negative regulation of transcription, DNA-templatedGO:00458929.1HEY2, MESP1, NKX2-5, ZFPM2
24multicellular organism developmentGO:00072759.0HEY2, MESP1, NKX2-5, NKX2-6
25positive regulation of transcription from RNA polymerase II promoterGO:00459449.0HEY2, MESP1, NKX2-5, ZFPM2

Molecular functions related to Tricuspid Atresia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1transcription factor bindingGO:00081349.2HEY2, NKX2-5, ZFPM2
2transcription factor activity, sequence-specific DNA bindingGO:00037008.9HEY2, MESP1, NKX2-5, NKX2-6

Sources for Tricuspid Atresia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet